Search results
Which Medication for Psoriasis Is Right for You?
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Lindsay Cook, PharmD Several viable treatment options are available for psoriasis, including topical creams, oral medications, and...
Eli Lilly: The Party Is Over
GuruFocus.com via Yahoo Finance· 5 months agoEli Lilly and Co. (NYSE:LLY) is an American pharmaceutical company that is one of the leaders in the global diabetes drugs market and is also beginning...
These 2 Numbers Could Spell Trouble for AbbVie Stock
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) investors might have a reason to start sweating. After a somewhat weak first quarter, the biopharma company's near future looks like...
Hammerling-Hodgers: There may be no cure for psoriasis, but there are ways to keep it in check
Florida Today via Yahoo News· 2 years agoSupport local journalism. A digital subscription is incredibly affordable and makes you the most...
What Are Biologics?
Health via Yahoo News· 6 months agoThe term “biologic” refers to a wide group of therapies used to treat many different types of medical conditions, such as rheumatoid arthritis and...
3 Magnificent Growth Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 2 months agoIn a sense, every investor is a growth investor. If you focus on valuation, you want to find bargain stocks that will grow more in the future than in the...
2 Beaten-Down Stocks to Buy Hand Over Fist This Year
Motley Fool via Yahoo Finance· 4 months agoWhile the market bounced back last year, some stocks failed to keep pace with broader equities. That was the case with pharma giant AbbVie (NYSE: ABBV)...
3 Top Healthcare Stocks to Buy for November
Motley Fool· 1 year agoCRISPR Therapeutics (NASDAQ: CRSP) is submitting what may become its first commercialized gene-editing treatment to regulators this month. Axsome...
Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal
Zacks via Yahoo Finance· 1 year agoPfizer (PFE) and Roivant Sciences (ROIV) form a new Roivant subsidiary to develop an inflammatory...
Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now
TipRanks via Yahoo Finance· 5 months agoBarring some outliers, the US large cap pharmaceutical group has underperformed the broader markets...